1. The document discusses autoimmunity and provides objectives, definitions, classifications, and details on important autoimmune diseases like SLE and Sjogren's syndrome.
2. SLE is characterized by a vast array of autoantibodies against nuclear antigens, causing injury via immune complex deposition. It can affect multiple organs and cause nephritis, skin lesions, arthritis, and hematologic and neurological issues.
3. Sjogren's syndrome is characterized by dry eyes and mouth due to immune-mediated destruction of lacrimal and salivary glands, resulting in keratoconjunctivitis sicca and xerostomia. It is believed to be caused by an autoimmune reaction against an
Autoimmunity occurs when the immune system fails to recognize self antigens and mounts an immune response against the body's own cells and tissues, leading to autoimmune disease. The immune system normally develops tolerance through central and peripheral mechanisms to distinguish self from non-self. A breakdown in tolerance can result from genetic susceptibility and environmental triggers like infections that cause molecular mimicry or tissue damage releasing self antigens. Autoimmune diseases are classified as organ-specific if they target a single organ, or systemic if affecting multiple body systems.
This document provides an overview of autoimmune diseases. It discusses how a defect in the immune system can trigger autoimmunity and lists examples of autoimmune disorders like rheumatoid arthritis, Graves' disease, and Hashimoto's thyroiditis. The causes of autoimmunity include genetic susceptibility and environmental triggers like infections. Viruses can induce autoimmunity through molecular mimicry or by damaging tissues and exposing new antigens.
This document discusses autoimmunity and autoimmune diseases. It begins by defining autoimmunity as a breakdown of self-tolerance mechanisms that leads to an adaptive immune response against self-antigens. This can result in chronic inflammation and autoimmune disease. Several proposed mechanisms for how autoimmunity occurs are described, including defects in central and peripheral tolerance. Factors like genetics, hormones, infections, and environmental exposures are thought to contribute to loss of self-tolerance. The document then classifies and describes some examples of organ-specific and systemic autoimmune diseases in more detail.
Your body's immune system protects you from disease and infection. But if you have an autoimmune disease, your immune system attacks healthy cells in your body by mistake. Autoimmune diseases can affect many parts of the body.
No one is sure what causes autoimmune diseases. They do tend to run in families. Women - particularly African-American, Hispanic-American, and Native-American women - have a higher risk for some autoimmune diseases.
There are more than 80 types of autoimmune diseases, and some have similar symptoms. This makes it hard for your health care provider to know if you really have one of these diseases, and if so, which one. Getting a diagnosis can be frustrating and stressful. Often, the first symptoms are fatigue, muscle aches and a low fever. The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain and swelling.
The diseases may also have flare-ups, when they get worse, and remissions, when symptoms get better or disappear. Treatment depends on the disease, but in most cases one important goal is to reduce inflammation. Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response.
This document discusses autoimmunity, which occurs when the immune system mistakenly attacks the body's own tissues and organs. It describes how Paul Ehrlich first proposed the concept of "horror autotoxicus" to explain this phenomenon. The mechanisms of self-tolerance that normally prevent autoimmunity can fail, leading to either organ-specific or systemic autoimmune diseases. Examples of organ-specific diseases include Hashimoto's thyroiditis, pernicious anemia, and insulin-dependent diabetes mellitus. Systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis are examples of systemic autoimmune diseases provided.
The document summarizes a chapter about autoimmunity and autoimmune diseases from three perspectives:
1) It outlines several key autoimmune diseases, their causes from abnormal immune responses against self-antigens, and their symptoms.
2) It discusses the use of animal models to study the mechanisms and potential treatments of autoimmune diseases.
3) It examines current therapeutic approaches that aim to suppress autoimmune responses through drugs or removal of target organs, and potential alternative strategies like inducing tolerance to self-antigens.
1. The document discusses autoimmunity and provides objectives, definitions, classifications, and details on important autoimmune diseases like SLE and Sjogren's syndrome.
2. SLE is characterized by a vast array of autoantibodies against nuclear antigens, causing injury via immune complex deposition. It can affect multiple organs and cause nephritis, skin lesions, arthritis, and hematologic and neurological issues.
3. Sjogren's syndrome is characterized by dry eyes and mouth due to immune-mediated destruction of lacrimal and salivary glands, resulting in keratoconjunctivitis sicca and xerostomia. It is believed to be caused by an autoimmune reaction against an
Autoimmunity occurs when the immune system fails to recognize self antigens and mounts an immune response against the body's own cells and tissues, leading to autoimmune disease. The immune system normally develops tolerance through central and peripheral mechanisms to distinguish self from non-self. A breakdown in tolerance can result from genetic susceptibility and environmental triggers like infections that cause molecular mimicry or tissue damage releasing self antigens. Autoimmune diseases are classified as organ-specific if they target a single organ, or systemic if affecting multiple body systems.
This document provides an overview of autoimmune diseases. It discusses how a defect in the immune system can trigger autoimmunity and lists examples of autoimmune disorders like rheumatoid arthritis, Graves' disease, and Hashimoto's thyroiditis. The causes of autoimmunity include genetic susceptibility and environmental triggers like infections. Viruses can induce autoimmunity through molecular mimicry or by damaging tissues and exposing new antigens.
This document discusses autoimmunity and autoimmune diseases. It begins by defining autoimmunity as a breakdown of self-tolerance mechanisms that leads to an adaptive immune response against self-antigens. This can result in chronic inflammation and autoimmune disease. Several proposed mechanisms for how autoimmunity occurs are described, including defects in central and peripheral tolerance. Factors like genetics, hormones, infections, and environmental exposures are thought to contribute to loss of self-tolerance. The document then classifies and describes some examples of organ-specific and systemic autoimmune diseases in more detail.
Your body's immune system protects you from disease and infection. But if you have an autoimmune disease, your immune system attacks healthy cells in your body by mistake. Autoimmune diseases can affect many parts of the body.
No one is sure what causes autoimmune diseases. They do tend to run in families. Women - particularly African-American, Hispanic-American, and Native-American women - have a higher risk for some autoimmune diseases.
There are more than 80 types of autoimmune diseases, and some have similar symptoms. This makes it hard for your health care provider to know if you really have one of these diseases, and if so, which one. Getting a diagnosis can be frustrating and stressful. Often, the first symptoms are fatigue, muscle aches and a low fever. The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain and swelling.
The diseases may also have flare-ups, when they get worse, and remissions, when symptoms get better or disappear. Treatment depends on the disease, but in most cases one important goal is to reduce inflammation. Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response.
This document discusses autoimmunity, which occurs when the immune system mistakenly attacks the body's own tissues and organs. It describes how Paul Ehrlich first proposed the concept of "horror autotoxicus" to explain this phenomenon. The mechanisms of self-tolerance that normally prevent autoimmunity can fail, leading to either organ-specific or systemic autoimmune diseases. Examples of organ-specific diseases include Hashimoto's thyroiditis, pernicious anemia, and insulin-dependent diabetes mellitus. Systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis are examples of systemic autoimmune diseases provided.
The document summarizes a chapter about autoimmunity and autoimmune diseases from three perspectives:
1) It outlines several key autoimmune diseases, their causes from abnormal immune responses against self-antigens, and their symptoms.
2) It discusses the use of animal models to study the mechanisms and potential treatments of autoimmune diseases.
3) It examines current therapeutic approaches that aim to suppress autoimmune responses through drugs or removal of target organs, and potential alternative strategies like inducing tolerance to self-antigens.
Defective tolerance or regulation of self-reactive lymphocytes is the underlying cause of all autoimmune diseases. There are four known mechanisms that can lead to this regulatory failure: negative selection of autoreactive cells in the thymus, insufficient numbers or function of regulatory T cells, defective apoptosis of mature autoreactive lymphocytes, and inadequate inhibitory signaling through receptors on lymphocytes. Genetic factors like polymorphisms in MHC and non-MHC genes interact with environmental triggers like infections and tissue damage to induce the immunological abnormalities that result in autoimmunity. Molecular mimicry and bystander activation during infections can cause cross-reactivity between foreign and self-antigens.
The document discusses the molecular mechanisms of autoimmunity, including molecular mimicry, superantigens, epitope spreading, inappropriate MHC expression, polyclonal B cell activation by viruses and bacteria, and cytokine dysregulation. It also covers genes associated with autoimmunity, environmental factors like drugs and toxins, and sex differences in autoimmune diseases.
This document discusses autoimmunity, including its definition as an inappropriate immune response against self cells/tissues due to self-tolerance failure. Various triggers are described, such as genetic factors like certain HLA alleles associated with diseases, environmental factors like molecular mimicry between pathogens and self-antigens, and non-genetic host factors including immunodeficiencies. Numerous autoimmune diseases are detailed along with their antibody targets and clinical features. Diagnosis involves clinical exams, labs to detect autoantibodies, and biopsies. Treatment focuses on reducing inflammation through steroids, blocking cytokines/integrins/B cells, or more extreme measures like immunosuppressants.
This document discusses autoimmunity and autoimmune diseases. It begins by explaining how the immune system can mistakenly attack self-antigens, leading to autoimmunity. Several organ-specific and systemic autoimmune diseases are described in detail, including how they are mediated by direct cellular damage, stimulating or blocking autoantibodies. Current treatments aim to suppress the immune system generally but do not cure the underlying condition. Experimental therapies discussed include T-cell vaccination, peptide blockade of MHC molecules, and monoclonal antibodies.
This document discusses autoimmunity and provides examples of several autoimmune diseases. It begins by defining autoimmunity as an inappropriate immune response directed against self-components. It then discusses how failure to eliminate self-reactive lymphocytes during development can lead to autoimmunity. Several autoimmune diseases are described in detail, including the mechanisms, symptoms, and treatments. Animal models of autoimmune diseases are also discussed.
This document discusses the role of infections in triggering or exacerbating autoimmune diseases. It outlines four main mechanisms by which this can occur: molecular mimicry, epitope spreading, bystander activation, and exposure of cryptic antigens. Several examples of specific pathogens and the autoimmune diseases they may relate to are described in detail, including evidence from human studies and animal models. While links between certain infections and autoimmunity exist, direct evidence is still limited. Defining genetic risk factors may help understand disease pathogenesis in cases with a suspected infectious trigger.
This document discusses autoimmunity and its underlying mechanisms. Autoimmunity occurs when the immune system mistakenly attacks and destroys healthy body tissue. The immune system normally distinguishes self from non-self through mechanisms of central and peripheral tolerance that eliminate or inactivate self-reactive immune cells. A defect or breakdown in these tolerance mechanisms can lead to autoimmunity. Specific mechanisms that may cause this include exposure of normally hidden self-antigens, antigen alteration, molecular mimicry between foreign and self-antigens, emergence of forbidden self-reactive clones, and defects in regulatory T cells or other immune cells. Common autoimmune diseases are then classified as hematological, organ-specific, or systemic.
Autoimmunity is caused by a failure of self/non-self discrimination in the immune system. More than 40 human diseases are known to have an autoimmune origin, affecting 5-7% of adults, with women being affected more often than men. Left-handed individuals also seem to be more susceptible to autoimmune diseases than right-handed individuals, though the reasons for this are unclear. Common autoimmune diseases include rheumatoid arthritis, diabetes, Graves' disease, and myasthenia gravis. Potential causes of autoimmunity include the release of sequestered antigens, molecular mimicry between self and foreign antigens, genetic factors, and infections that dysregulate the immune response. Treatment options aim to suppress the immune
Autoimmunity occurs when the immune system loses tolerance to its own tissues and mounts an immune response against them. There are several potential mechanisms for this loss of tolerance, including molecular mimicry between foreign and self antigens, sequestered self antigens being exposed to the immune system, and failures of regulatory mechanisms that normally suppress autoreactive immune cells. Autoimmune diseases result when this autoreactivity causes tissue damage. Examples include diseases caused by autoantibodies like rheumatoid arthritis, Graves' disease, and Hashimoto's thyroiditis, as well as those caused by autoreactive T cells like multiple sclerosis and insulin-dependent diabetes.
This document discusses autoimmunity, including:
- What autoimmunity is, the history of its discovery, and proposed mechanisms. Mechanisms include sequestered antigens, escape of autoreactive clones, loss of regulatory T cells, cross-reactive antigens, and altered self antigens.
- Types of autoimmune diseases classified by organ specificity, systemic diseases, pathogenic organisms involved, and type of hypersensitivity reaction. Examples are given for each category.
- Laboratory diagnosis of autoimmune diseases including routine tests, autoantibodies like ANA and RF, acute phase proteins, and HLA typing. Specific autoantibody patterns are shown.
- Treatment approaches including symptomatic treatments and immunosuppressive agents like ant
Autoimmune diseases occur when the immune system attacks the body's own tissues and organs. There are several mechanisms that normally prevent this, including central tolerance in the thymus and bone marrow, and peripheral tolerance by regulatory T cells. A failure of these tolerance mechanisms can result in autoimmune diseases. Genetic and environmental factors also contribute to predisposing individuals. Autoimmune diseases can be organ-specific or affect multiple systems. Diagnosis involves detecting elevated levels of autoantibodies through various tests. Treatment aims to suppress immune induction and restore tolerance, as well as inhibit effector mechanisms causing organ damage.
Autoimmune diseases occur when the immune system attacks the body's own cells and tissues. They represent a significant health burden, affecting 3-9% of the population. The immune system normally maintains tolerance to self-antigens but in autoimmunity this tolerance fails. Autoimmune diseases can be systemic, targeting ubiquitous antigens, or organ-specific, targeting particular tissues. Genetic, environmental, and hormonal factors all contribute to autoimmune disease susceptibility. Treatments aim to suppress the immune system or its inflammatory responses.
This document provides an overview of autoimmunity. It defines autoimmunity as the immune system attacking the body's own tissues, discusses the history of the field and how tolerance normally prevents this, and lists factors that can disrupt tolerance and lead to autoimmune disease. Some key autoimmune diseases are then described, along with criteria for diagnosing autoimmune conditions.
The document discusses autoimmune diseases and focuses on systemic lupus erythematosus (SLE). It describes SLE as an autoimmune disease involving multiple organs characterized by autoantibodies targeting various cells and tissues. The key mechanisms involved in SLE include genetic factors like HLA alleles, defects in immunologic tolerance, abnormal display of self antigens, and inflammation triggered by infections. The document outlines the clinical features of SLE and the spectrum of autoantibodies associated with it, with antibodies to double-stranded DNA and Smith antigen being virtually diagnostic of SLE.
This document discusses autoimmune diseases, including their mechanisms, animal models, organ-specific and systemic forms, diagnosis, and treatment approaches. It defines autoimmunity as the immune system mistakenly attacking the body's own tissues. The mechanisms discussed include molecular mimicry, failure of self-tolerance, and abnormal immune responses. Organ-specific diseases covered are Graves' disease, myasthenia gravis, IDDM, and others. Systemic diseases discussed include rheumatoid arthritis, SLE, Sjogren's syndrome, and more. Diagnosis and treatment focus on identifying autoantibodies, immunosuppressants, monoclonal antibodies, and other targeted therapies.
This document discusses the diagnosis of autoimmune diseases. It describes several markers that provide evidence of autoimmune diseases, such as a positive family history, presence of other autoimmune diseases, infiltrating cells in affected tissues, and improvement with immunosuppressive drugs. It also discusses several mechanisms that can lead to autoimmunity, including antigenic alteration, sequestered antigens, molecular mimicry, and polyclonal B cell activation. Common diagnostic methods are also summarized, including initial laboratory evaluation, immunological studies, and detection of autoantibodies through enzyme-linked immunosorbent assays (ELISAs).
Autoimmune diseases occur when the immune system mistakenly attacks and damages healthy body tissues. There are over 80 types of autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The causes are not fully understood but may involve genetic and environmental factors. Common treatments aim to suppress the immune system to reduce symptoms, though diagnosis and treatment can be challenging given the wide variation in symptoms and tissues affected across different autoimmune diseases.
This document provides an overview of autoimmune diseases including causes, types, links to HLA genes, treatment approaches, and mouse models. It discusses three main types of autoimmune diseases: haemolytic, localized, and systemic. Examples like Hashimoto's thyroiditis, myasthenia gravis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus, and rheumatoid arthritis are explained. The roles of HLA genes and immunosuppressive drugs in treatment are also summarized. Mouse models that replicate human autoimmune conditions are noted.
The document discusses immune responses and immune-related diseases. It covers four types of diseases that can result from issues with the immune system: 1) inadequate immune response (immunodeficiency), 2) inappropriate immune response (autoimmune diseases and graft rejection), 3) excessive immune response (hypersensitivity), and 4) amyloidosis. It provides examples and details of primary and secondary immunodeficiencies, transplant rejection, autoimmune diseases, HIV/AIDS, and opportunistic infections seen in AIDS patients.
This document provides an overview of the immune response and immune system. It describes the mechanisms of innate immunity including anatomical, physiological, cellular, and inflammatory barriers that provide non-specific protection. Adaptive immunity is induced when innate immunity fails, and has antigen specificity and immunological memory. B and T lymphocytes mediate humoral and cell-mediated immunity respectively. The process of phagocytosis and antibody production are explained. Primary and secondary immune responses differ in lag period, magnitude, and antibody class. Innate and adaptive immunity cooperate to eliminate pathogens.
Defective tolerance or regulation of self-reactive lymphocytes is the underlying cause of all autoimmune diseases. There are four known mechanisms that can lead to this regulatory failure: negative selection of autoreactive cells in the thymus, insufficient numbers or function of regulatory T cells, defective apoptosis of mature autoreactive lymphocytes, and inadequate inhibitory signaling through receptors on lymphocytes. Genetic factors like polymorphisms in MHC and non-MHC genes interact with environmental triggers like infections and tissue damage to induce the immunological abnormalities that result in autoimmunity. Molecular mimicry and bystander activation during infections can cause cross-reactivity between foreign and self-antigens.
The document discusses the molecular mechanisms of autoimmunity, including molecular mimicry, superantigens, epitope spreading, inappropriate MHC expression, polyclonal B cell activation by viruses and bacteria, and cytokine dysregulation. It also covers genes associated with autoimmunity, environmental factors like drugs and toxins, and sex differences in autoimmune diseases.
This document discusses autoimmunity, including its definition as an inappropriate immune response against self cells/tissues due to self-tolerance failure. Various triggers are described, such as genetic factors like certain HLA alleles associated with diseases, environmental factors like molecular mimicry between pathogens and self-antigens, and non-genetic host factors including immunodeficiencies. Numerous autoimmune diseases are detailed along with their antibody targets and clinical features. Diagnosis involves clinical exams, labs to detect autoantibodies, and biopsies. Treatment focuses on reducing inflammation through steroids, blocking cytokines/integrins/B cells, or more extreme measures like immunosuppressants.
This document discusses autoimmunity and autoimmune diseases. It begins by explaining how the immune system can mistakenly attack self-antigens, leading to autoimmunity. Several organ-specific and systemic autoimmune diseases are described in detail, including how they are mediated by direct cellular damage, stimulating or blocking autoantibodies. Current treatments aim to suppress the immune system generally but do not cure the underlying condition. Experimental therapies discussed include T-cell vaccination, peptide blockade of MHC molecules, and monoclonal antibodies.
This document discusses autoimmunity and provides examples of several autoimmune diseases. It begins by defining autoimmunity as an inappropriate immune response directed against self-components. It then discusses how failure to eliminate self-reactive lymphocytes during development can lead to autoimmunity. Several autoimmune diseases are described in detail, including the mechanisms, symptoms, and treatments. Animal models of autoimmune diseases are also discussed.
This document discusses the role of infections in triggering or exacerbating autoimmune diseases. It outlines four main mechanisms by which this can occur: molecular mimicry, epitope spreading, bystander activation, and exposure of cryptic antigens. Several examples of specific pathogens and the autoimmune diseases they may relate to are described in detail, including evidence from human studies and animal models. While links between certain infections and autoimmunity exist, direct evidence is still limited. Defining genetic risk factors may help understand disease pathogenesis in cases with a suspected infectious trigger.
This document discusses autoimmunity and its underlying mechanisms. Autoimmunity occurs when the immune system mistakenly attacks and destroys healthy body tissue. The immune system normally distinguishes self from non-self through mechanisms of central and peripheral tolerance that eliminate or inactivate self-reactive immune cells. A defect or breakdown in these tolerance mechanisms can lead to autoimmunity. Specific mechanisms that may cause this include exposure of normally hidden self-antigens, antigen alteration, molecular mimicry between foreign and self-antigens, emergence of forbidden self-reactive clones, and defects in regulatory T cells or other immune cells. Common autoimmune diseases are then classified as hematological, organ-specific, or systemic.
Autoimmunity is caused by a failure of self/non-self discrimination in the immune system. More than 40 human diseases are known to have an autoimmune origin, affecting 5-7% of adults, with women being affected more often than men. Left-handed individuals also seem to be more susceptible to autoimmune diseases than right-handed individuals, though the reasons for this are unclear. Common autoimmune diseases include rheumatoid arthritis, diabetes, Graves' disease, and myasthenia gravis. Potential causes of autoimmunity include the release of sequestered antigens, molecular mimicry between self and foreign antigens, genetic factors, and infections that dysregulate the immune response. Treatment options aim to suppress the immune
Autoimmunity occurs when the immune system loses tolerance to its own tissues and mounts an immune response against them. There are several potential mechanisms for this loss of tolerance, including molecular mimicry between foreign and self antigens, sequestered self antigens being exposed to the immune system, and failures of regulatory mechanisms that normally suppress autoreactive immune cells. Autoimmune diseases result when this autoreactivity causes tissue damage. Examples include diseases caused by autoantibodies like rheumatoid arthritis, Graves' disease, and Hashimoto's thyroiditis, as well as those caused by autoreactive T cells like multiple sclerosis and insulin-dependent diabetes.
This document discusses autoimmunity, including:
- What autoimmunity is, the history of its discovery, and proposed mechanisms. Mechanisms include sequestered antigens, escape of autoreactive clones, loss of regulatory T cells, cross-reactive antigens, and altered self antigens.
- Types of autoimmune diseases classified by organ specificity, systemic diseases, pathogenic organisms involved, and type of hypersensitivity reaction. Examples are given for each category.
- Laboratory diagnosis of autoimmune diseases including routine tests, autoantibodies like ANA and RF, acute phase proteins, and HLA typing. Specific autoantibody patterns are shown.
- Treatment approaches including symptomatic treatments and immunosuppressive agents like ant
Autoimmune diseases occur when the immune system attacks the body's own tissues and organs. There are several mechanisms that normally prevent this, including central tolerance in the thymus and bone marrow, and peripheral tolerance by regulatory T cells. A failure of these tolerance mechanisms can result in autoimmune diseases. Genetic and environmental factors also contribute to predisposing individuals. Autoimmune diseases can be organ-specific or affect multiple systems. Diagnosis involves detecting elevated levels of autoantibodies through various tests. Treatment aims to suppress immune induction and restore tolerance, as well as inhibit effector mechanisms causing organ damage.
Autoimmune diseases occur when the immune system attacks the body's own cells and tissues. They represent a significant health burden, affecting 3-9% of the population. The immune system normally maintains tolerance to self-antigens but in autoimmunity this tolerance fails. Autoimmune diseases can be systemic, targeting ubiquitous antigens, or organ-specific, targeting particular tissues. Genetic, environmental, and hormonal factors all contribute to autoimmune disease susceptibility. Treatments aim to suppress the immune system or its inflammatory responses.
This document provides an overview of autoimmunity. It defines autoimmunity as the immune system attacking the body's own tissues, discusses the history of the field and how tolerance normally prevents this, and lists factors that can disrupt tolerance and lead to autoimmune disease. Some key autoimmune diseases are then described, along with criteria for diagnosing autoimmune conditions.
The document discusses autoimmune diseases and focuses on systemic lupus erythematosus (SLE). It describes SLE as an autoimmune disease involving multiple organs characterized by autoantibodies targeting various cells and tissues. The key mechanisms involved in SLE include genetic factors like HLA alleles, defects in immunologic tolerance, abnormal display of self antigens, and inflammation triggered by infections. The document outlines the clinical features of SLE and the spectrum of autoantibodies associated with it, with antibodies to double-stranded DNA and Smith antigen being virtually diagnostic of SLE.
This document discusses autoimmune diseases, including their mechanisms, animal models, organ-specific and systemic forms, diagnosis, and treatment approaches. It defines autoimmunity as the immune system mistakenly attacking the body's own tissues. The mechanisms discussed include molecular mimicry, failure of self-tolerance, and abnormal immune responses. Organ-specific diseases covered are Graves' disease, myasthenia gravis, IDDM, and others. Systemic diseases discussed include rheumatoid arthritis, SLE, Sjogren's syndrome, and more. Diagnosis and treatment focus on identifying autoantibodies, immunosuppressants, monoclonal antibodies, and other targeted therapies.
This document discusses the diagnosis of autoimmune diseases. It describes several markers that provide evidence of autoimmune diseases, such as a positive family history, presence of other autoimmune diseases, infiltrating cells in affected tissues, and improvement with immunosuppressive drugs. It also discusses several mechanisms that can lead to autoimmunity, including antigenic alteration, sequestered antigens, molecular mimicry, and polyclonal B cell activation. Common diagnostic methods are also summarized, including initial laboratory evaluation, immunological studies, and detection of autoantibodies through enzyme-linked immunosorbent assays (ELISAs).
Autoimmune diseases occur when the immune system mistakenly attacks and damages healthy body tissues. There are over 80 types of autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The causes are not fully understood but may involve genetic and environmental factors. Common treatments aim to suppress the immune system to reduce symptoms, though diagnosis and treatment can be challenging given the wide variation in symptoms and tissues affected across different autoimmune diseases.
This document provides an overview of autoimmune diseases including causes, types, links to HLA genes, treatment approaches, and mouse models. It discusses three main types of autoimmune diseases: haemolytic, localized, and systemic. Examples like Hashimoto's thyroiditis, myasthenia gravis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus, and rheumatoid arthritis are explained. The roles of HLA genes and immunosuppressive drugs in treatment are also summarized. Mouse models that replicate human autoimmune conditions are noted.
The document discusses immune responses and immune-related diseases. It covers four types of diseases that can result from issues with the immune system: 1) inadequate immune response (immunodeficiency), 2) inappropriate immune response (autoimmune diseases and graft rejection), 3) excessive immune response (hypersensitivity), and 4) amyloidosis. It provides examples and details of primary and secondary immunodeficiencies, transplant rejection, autoimmune diseases, HIV/AIDS, and opportunistic infections seen in AIDS patients.
This document provides an overview of the immune response and immune system. It describes the mechanisms of innate immunity including anatomical, physiological, cellular, and inflammatory barriers that provide non-specific protection. Adaptive immunity is induced when innate immunity fails, and has antigen specificity and immunological memory. B and T lymphocytes mediate humoral and cell-mediated immunity respectively. The process of phagocytosis and antibody production are explained. Primary and secondary immune responses differ in lag period, magnitude, and antibody class. Innate and adaptive immunity cooperate to eliminate pathogens.
This document summarizes a presentation on food processing and health. It discusses several topics:
1) Chronic inflammation and its links to disease. Processed foods high in trans fats, AGEs, and acrylamides can promote inflammation.
2) Trans fats are linked to increased risk of cardiovascular disease. International regulations are reducing trans fat levels in foods.
3) Advanced glycation end-products (AGEs) form during cooking and are associated with oxidative stress and diseases like diabetes. Grilling and frying increase AGE levels in foods.
4) Heating oils can damage their quality and produce harmful compounds. Choosing oils with high smoke points is recommended for cooking methods like deep frying.
This document discusses immunological tolerance and autoimmunity. It defines central and peripheral tolerance as mechanisms by which the immune system learns to distinguish self from non-self. Central tolerance involves deletion of self-reactive lymphocytes in the thymus and bone marrow. Peripheral tolerance mechanisms include clonal deletion, anergy, and suppression. Failure of tolerance can lead to autoimmune diseases, which are influenced by genetic, hormonal, and environmental factors. Common triggers include molecular mimicry between microbial and self-antigens.
This document discusses autoimmune diseases from several perspectives in 3 paragraphs:
1) It provides an overview of autoimmune diseases, their causes, epidemiology, and challenges in treatment. Many diseases are difficult to cure as the immune response targets self-antigens. Genetics and the environment both contribute to disease risk.
2) It examines the role of single gene disorders in autoimmunity, highlighting specific genes like AIRE, FOXP3, and FAS that impact central and peripheral tolerance when mutated.
3) It explores the genetics and immune features of complex autoimmune diseases, which involve multiple genetic and environmental factors. Various cell types, cytokines, autoantibodies, and complement activation can drive pathogenesis
Haemophilus species are small, gram-negative bacteria that require enriched media containing blood or its derivatives to grow. H. influenzae type b is an important human pathogen causing meningitis in children and respiratory infections. H. ducreyi causes the sexually transmitted disease chancroid. While some species are normal flora, H. influenzae type b is a leading cause of bacterial meningitis in children aged 5 months to 5 years. Widespread use of H. influenzae type b conjugate vaccines has reduced the incidence of meningitis by over 95%.
This document discusses angiogenesis, invasion, and metastasis. Angiogenesis is the formation of new blood vessels from pre-existing vessels and involves a balance of pro- and anti-angiogenic factors like VEGF, FGF, thrombospondin. The metastatic cascade refers to the series of events by which tumor cells form secondary growths, including invasion of the extracellular matrix through degradation enzymes, vascular dissemination, and homing and colonization at distant sites. Molecular genetics models suggest metastases develop through clonal evolution as mutations accumulate subsets of cells able to complete the metastatic steps.
This document summarizes different types of immunity and hypersensitivity reactions. It describes two broad categories of immunity: innate immunity which provides a first line of defense, and adaptive immunity which develops after exposure and recognizes specific antigens. It then discusses four types of hypersensitivity reactions (Type I-IV) mediated by different immune mechanisms in response to various antigens, providing examples of diseases associated with each type.
1. Immune tolerance occurs when the immune system fails to respond to an antigen it has previously been exposed to, resulting in non-reactivity to that antigen. Tolerance is important for avoiding autoimmune reactions to self-antigens.
2. Tolerance can occur through several mechanisms, including clonal deletion of autoreactive T and B cells in the thymus and bone marrow, clonal anergy of autoreactive cells, ignorance of sequestered self-antigens, and receptor editing of B cells.
3. Autoimmunity results from a loss of self-tolerance and an immune response against self-components. It can be organ-specific or systemic. Causes of autoimmunity
1. Angiogenesis is the process of forming new blood vessels from pre-existing vessels.
2. In 1971, Dr. Judah Folkman hypothesized that tumor growth depends on angiogenesis and published this theory, which was initially rejected.
3. Since the 1970s, many important discoveries have been made regarding angiogenic factors like VEGF and angiogenesis inhibitors.
This document discusses different types of hypersensitivity and immunopathology. It covers four main types of hypersensitivity reactions (Type I-IV) that vary in severity from mild to life-threatening. Type I is an immediate reaction mediated by IgE antibodies and mast cells. Type II involves IgG and IgM antibodies against cell surface antigens. Type III reactions are caused by immune complexes circulating in the bloodstream. Type IV is a delayed hypersensitivity mediated by T cells. The document also discusses autoimmune disease, where the immune system attacks the body's own tissues, and immunodeficiencies that increase susceptibility to infection.
The document discusses antibiotics, including their sources, roles, classification, and mechanisms of action. It focuses on several classes of antibiotics that act by inhibiting bacterial cell wall synthesis or protein synthesis. It describes how penicillins and cephalosporins inhibit the final stage of peptidoglycan synthesis in bacterial cell walls. It also discusses how other drugs like glycopeptides, fosfomycins, and aminoglycosides act on bacterial cell components and physiological processes. The classification, mechanisms of action and spectra of several classes of protein synthesis inhibitors are outlined as well.
This document discusses autoimmune diseases, specifically systemic lupus erythematosus (SLE). It describes how SLE results from a loss of self-tolerance causing autoantibodies or autoreactive cells to damage organs. Key points are that SLE is associated with over 25 autoantibodies, most notably double-stranded DNA antibodies and antihistone antibodies. Diagnosis involves screening for antinuclear antibodies via fluorescent antinuclear antibody testing, with double-stranded DNA antibodies being highly specific for SLE diagnosis. The disease presents with diverse, nonspecific symptoms and can affect many organ systems like the skin, joints, and kidneys.
The document provides an overview of immunology topics covered in a course, including the immune system and disease, immunopathology, and therapeutic applications. The course covers basics of the immune system, innate and adaptive immunity, cells and molecules of the immune system, and applications like immunization, transplantation, and immunotherapy. Immunopathology topics include immunodeficiency, autoimmunity, hypersensitivity, and malignancies of the immune system. Therapeutic applications focus on immunization, immunomodulation, transplantation, immunosuppression, and replacement therapies.
During this webinar, Sophie discusses the inflammatory basis of autoimmune conditions and the nutritional approach to managing inflammation, together with therapeutic nutrients to support specific autoimmune conditions.
Autoimmune diseases include over 50 modern conditions including coeliac disease, reactive arthritis, hashimoto’s disease, type 1 diabetes, lupus, multiple sclerosis and many more. Inflammation is at the root of autoimmunity and during this webinar Sophie discusses how dysregulation of the inflammatory response contributes to autoimmune issues, together with the latest research being conducted to determine the role of nutrition in the treatment and prevention of autoimmune conditions.
This document outlines the topics that will be covered in a course on immunology, including: the basics of the immune system and disease; immunopathology; and therapeutic applications of immunology. The course will cover the structure and function of the immune system, cells and molecules involved, innate and adaptive immunity, immunodeficiencies, autoimmunity, hypersensitivities, lymphoproliferative diseases, and clinical immunology. References and resources will include lecture notes, textbooks, and online materials.
This document summarizes key concepts in immunology, including innate and acquired immunity, antigens, antibodies, immunoglobulins, the structure of the immune system, hypersensitivity, autoimmunity, and more. It discusses the immune response and mechanisms like the complement system. It also provides an overview of COVID-19, describing transmission, variants of concern, treatments including vaccines, and more. The document concludes with important definitions and concepts in immunology.
The document summarizes the key differences between innate and adaptive immunity. Innate immunity is present from birth and provides non-specific resistance to pathogens. It involves anatomical barriers, phagocytes, complement proteins, cytokines and other cellular components. Adaptive immunity is acquired during life and provides pathogen-specific resistance through T cells, B cells, antibodies, immunological memory and specificity. Dendritic cells, macrophages, complement pathways and cytokines act as bridges between the innate and adaptive immune systems.
The document discusses various topics related to immunology including innate immunity, acquired immunity, active immunity, passive immunity, factors influencing innate immunity, a comparison of active and passive immunity, the mechanisms of innate immunity, local immunity, herd immunity, adoptive immunity, vaccines, cell-mediated immunity, and antibody-mediated immunity. It also briefly mentions severe combined immunodeficiency disorder, otherwise known as "bubble boy disease".
This document provides an overview of immunity and the principles of vaccination. It discusses the immune system and the types of immunity, including innate and adaptive immunity. It describes how vaccines work, the goals of vaccination, and examples of different types of vaccines including bacterial, viral, and cancer vaccines. Challenges to developing an HIV vaccine are also summarized.
This document provides an overview of immunity and the principles of vaccination. It discusses the immune system and the types of immunity, including innate and adaptive immunity. It describes how vaccines work, the goals of vaccination, and examples of different types of vaccines including bacterial, viral, and cancer vaccines. Challenges to developing an HIV vaccine are also summarized.
Immunology of tanslanatation and malignancyraghunathp
This document discusses immunology of transplantation and malignancy. It defines transplantation as transferring cells, tissues or organs from one site to another. The first- and second-set rejection of allografts is described, where a second graft from the same donor is rejected more quickly. Tumor cells can induce immune responses as they express new antigens foreign to the host. However, tumors can escape immunosurveillance through various mechanisms like weak immunogenicity or suppression of the immune response. Immunotherapy approaches aim to enhance these immune responses through both active and passive methods.
1) The document discusses innate immunity, which provides the first line of host defense against infection through recognition of microbial and damaged self molecules. (2) It describes the cellular and soluble components of innate immunity, including phagocytes, dendritic cells, NK cells, complement proteins, and antimicrobial peptides. (3) Pattern recognition receptors (PRRs) play a key role in innate immunity by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to initiate inflammatory responses and stimulate adaptive immunity.
The document discusses immunosurveillance, which is the concept that the immune system prevents tumour development by detecting and eliminating abnormal cells. It provides a history of the theory and describes the mechanisms by which the immune system responds to tumour antigens through cellular and humoral responses. However, tumours can evade the immune system through mechanisms like antigen loss or suppression of immune cells. While the immune system plays a role in controlling cancer, its theory is imperfect as tumours still develop, requiring updated concepts like cancer immunoediting.
The document discusses host defense mechanisms against pathogens. It describes three lines of defense: 1) physical barriers like skin and mucous membranes, 2) inflammatory response and defensive cells, and 3) the immune system. The immune system has both innate and acquired branches. Innate immunity provides non-specific protection using physical and chemical barriers while acquired immunity involves adaptive, antigen-specific responses. Key cells of the immune system that provide defense include macrophages, neutrophils, lymphocytes and natural killer cells. Antibodies and the complement system are important components that help eliminate pathogens.
This document provides an overview of immunity, including definitions, classifications, and mechanisms. It discusses innate immunity, which is present at birth, and acquired immunity, which develops after birth through active or passive transfer. Innate immunity involves nonspecific defenses like epithelial barriers, antimicrobial proteins, inflammation, and phagocytes. Acquired immunity can be active, developing from natural infection or vaccination, or passive, through maternal antibody transfer or administration of antiserum. The document also briefly mentions local immunity at infection sites and herd immunity within communities.
Introduction to Immunity Antibody Function & Diversity 2006 L1&2-overview & AbLionel Wolberger
This document provides an overview of a lecture on antibody function and diversity. It introduces antibody gene rearrangement and discusses how antibodies recognize an almost infinite number of antigens through genetic diversity mechanisms like variable gene segments and junctional diversity during lymphocyte development. Key textbooks on immunology are also referenced.
This document discusses the history and key concepts of immunology. It describes some of the earliest observations of immunity in the 4th century BC by Thucydides. It then outlines major developments in vaccination by Jenner in 1790 and the later proposals of the germ theory of disease by Pasteur and the concept of acquired cellular immunity by Metchnikoff and Ehrlich in the late 19th century. The document also summarizes the three lines of defense in the immune system (non-specific, specific, and adaptive immunity), the roles of antibodies, B cells and T cells, and the processes of humoral and cell-mediated immunity.
This document defines and describes different types of immunodeficiencies. It discusses primary and secondary immunodeficiencies, listing some common examples like DiGeorge's Syndrome. It then summarizes the main features of deficiencies in antibodies, T cells, neutrophils, and complement. Finally, it briefly discusses acquired immunodeficiency syndrome (AIDS) caused by HIV infection.
The document discusses innate immunity. It describes the components of innate immunity including epithelial surfaces, antimicrobial substances in blood and tissues, fever, acute phase proteins, and cells of the innate immune system such as phagocytes (macrophages and neutrophils), mast cells, basophils, eosinophils, and platelets. These components provide non-specific defenses that help the body resist infection.
This document provides an overview of immunology and immunity. It discusses the study of immunology, the function of the immune system including innate immunity, acquired immunity, antigens, and the effects of age on the immune response. Innate immunity provides non-specific protection through physical and chemical barriers while acquired immunity develops specific responses with immunological memory after exposure to antigens. Both humoral and cell-mediated immunity play important roles in the immune response to infection.
Basic immunology- Dr.Pankti Shah (PART I MDS)PanktiShah12
This document provides an overview of immunology and the immune system as it relates to dental bacterial plaque and periodontitis. It defines key terms like immunity, antigens, antibodies, and the antigen-antibody reaction. It describes the different types of immunity and components of the immune system including the complement system. It discusses the inflammatory response in the periodontium and potential for periodontal vaccines. It also covers the immunology of dental bacterial plaque and the roles of antibodies, complement activation, chemotaxis, phagocytosis, and T and B lymphocytes in the immune response to caries, gingivitis and periodontitis.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
The simplified electron and muon model, Oscillating Spacetime: The Foundation...RitikBhardwaj56
Discover the Simplified Electron and Muon Model: A New Wave-Based Approach to Understanding Particles delves into a groundbreaking theory that presents electrons and muons as rotating soliton waves within oscillating spacetime. Geared towards students, researchers, and science buffs, this book breaks down complex ideas into simple explanations. It covers topics such as electron waves, temporal dynamics, and the implications of this model on particle physics. With clear illustrations and easy-to-follow explanations, readers will gain a new outlook on the universe's fundamental nature.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
13. MHC class II molecules Not any peptide will fit in the groove but multiple possibilities per molecule (20-24 aa) Some peptide will have a better “fit” in one isotype vs the other
22. Genetic Antigenic Peptide Genetic Factors in RA HLA-DRw4 alleles Shared Epitope (SE) Birth Imboden J. Annu. Rev. Pathol. Mech. Dis. 2009. 4:417-434
23. Genetic Onset of Autoimmunity Environmental Inflammation & Bone Erosion CCP RA Timeline Birth Pre-clinical Clinical Symptoms Adult Life
24. BREAKTHROUGH IN RA Autoimmunity to citrullinated protein antigens has specificity for RA and identifies a clinically and genetically distinct form of RA Environmental 70% of RA patients are anti-CCP+ Environmental Factors in RA Adult Life
25. Environmental Environmental Factors in RA Process exist constitutively and occurs in healthy individuals. Citrullinated proteins are found in sites of inflammation including joints but are not specific to RA Adult Life However the loss of tolerance is the event specific for RA
29. Genetic Onset of Autoimmunity Environmental Inflammation & Bone Erosion Observed up to 10 years before onset of disease* CCP RA Timeline + = Therefore Joint inflammation is not a requirement for the development of anti-CCP antibodies Birth Pre-clinical Clinical Symptoms Adult Life * Klareskog et al. Ann Rheum Dis 2004; 63(Suppl II): ii28-ii33
33. Pathogenesis of RA J. Clin. Invest. 118:3537–3545 (2008). doi:10.1172/JCI36389
34. Current Biologic agents in RA Infliximab Adalimumab Golimumab CertolizumabPegol Etanercept Ustekinumab Tocilizumab Abatacept Rituximab Infliximab Adalimumab Rituximab Adapted from Chan et al. Nature Reviews Immunology, May 2010; v10; p301-316
35. Current Biologic agents in RA - - - - Abatacept Rituximab Tocilizumab Anti-TNF Anakinra - - Nature Reviews Rheumatology 5, 531-541 (October 2009)
36. Genetic Susceptibility (HLA-DRw4) Inflammation Cytokines Pathways Citrullination of antigens in the joints Bone Erosion Environment (e.g Smoking) Immune Complexes Activation of the complement Summary Anti-CCP antibodies Insult in the joints
37. Genetic Susceptibility (HLA-DRw4) Inflammation Cytokines Pathways Citrullination of antigens in the joints Bone Erosion Environment (e.g Smoking) Immune Complexes Activation of the complement Summary Anti-CCP antibodies Insult in the joints ?